{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:16:55Z","timestamp":1778743015024,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2502700"],"award-info":[{"award-number":["2022YFC2502700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SKY2023192"],"award-info":[{"award-number":["SKY2023192"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SYW2024024"],"award-info":[{"award-number":["SYW2024024"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SYW2024055"],"award-info":[{"award-number":["SYW2024055"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SKY2022170"],"award-info":[{"award-number":["SKY2022170"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BE2022732"],"award-info":[{"award-number":["BE2022732"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20220047"],"award-info":[{"award-number":["BK20220047"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373414"],"award-info":[{"award-number":["82373414"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300182"],"award-info":[{"award-number":["82300182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203442"],"award-info":[{"award-number":["82203442"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404067"],"award-info":[{"award-number":["82404067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.cellsig.2025.111980","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T15:37:40Z","timestamp":1752593860000},"page":"111980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["KIF11 promotes AML progression, and its inhibition by SB-743921 suppresses disease advancement through mitotic G2\/M phase arrest"],"prefix":"10.1016","volume":"135","author":[{"given":"Linbo","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanjuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengmeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zong","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongli","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zimu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peifang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2025.111980_bb0005","article-title":"Advances in acute myeloid leukemia","volume":"375","author":"Newell","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111980_bb0010","first-page":"38","article-title":"Acute myeloid leukemia: a review","volume":"103","author":"Pelcovits","year":"2020","journal-title":"R. I. Med. J."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111980_bb0015","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ajh.26822","article-title":"Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Shimony","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111980_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2025.111980_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","author":"Jordan","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2025.111980_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/S1471-4892(01)00064-9","article-title":"Past and future of the mitotic spindle as an oncology target","author":"Wood","year":"2001","journal-title":"Curr. Opin. Pharmacol."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111980_bb0035","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/leu.2009.101","article-title":"Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells","volume":"23","author":"Carter","year":"2009","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111980_bb0040","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrc3310","article-title":"Kinesins and cancer","volume":"12","author":"Rath","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2025.111980_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.02.016","article-title":"KIF11 inhibitors filanesib and ispinesib inhibit meningioma growth in vitro and in vivo","volume":"506","author":"Jungwirth","year":"2021","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111980_bb0050","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3109\/10428194.2014.956319","article-title":"Kinesin spindle protein inhibitor SB743921 induces mitotic arrest and apoptosis and overcomes imatinib resistance of chronic myeloid leukemia cells","volume":"56","author":"Yin","year":"2015","journal-title":"Leuk. Lymphoma"},{"issue":"9","key":"10.1016\/j.cellsig.2025.111980_bb0055","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/CAD.0000000000000402","article-title":"KSP inhibitor SB743921 inhibits growth and induces apoptosis of breast cancer cells by regulating p53, Bcl-2, and DTL","volume":"27","author":"Zhu","year":"2016","journal-title":"Anticancer Drugs"},{"issue":"7","key":"10.1016\/j.cellsig.2025.111980_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111980_bb0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MOP.0000000000000855","article-title":"Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy","volume":"32","author":"Elgarten","year":"2020","journal-title":"Curr. Opin. Pediatr."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111980_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13045-017-0543-7","article-title":"Precision therapy for acute myeloid leukemia","volume":"11","author":"Yang","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111980_bb0075","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1021\/jm3014597","article-title":"Optimized S-trityl-L-cysteine-based inhibitors of kinesin spindle protein with potent in vivo antitumor activity in lung cancer xenograft models","volume":"56","author":"Good","year":"2013","journal-title":"J. Med. Chem."},{"issue":"39","key":"10.1016\/j.cellsig.2025.111980_bb0080","doi-asserted-by":"crossref","first-page":"20283","DOI":"10.1074\/jbc.M116.730697","article-title":"The Kinesin-5 Chemomechanical cycle is dominated by a two-heads-bound state","volume":"291","author":"Chen","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111980_bb0085","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.3109\/10428194.2015.1020058","article-title":"The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphoma","volume":"56","author":"Bongero","year":"2015","journal-title":"Leuk. Lymphoma"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111980_bb0090","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/cas.12138","article-title":"Oncogenic role of kinesin proteins and targeting kinesin therapy","volume":"104","author":"Liu","year":"2013","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111980_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/biom14040386","article-title":"Mitotic functions and characters of KIF11 in cancers","volume":"14","author":"Gao","year":"2024","journal-title":"Biomolecules"},{"issue":"47","key":"10.1016\/j.cellsig.2025.111980_bb0100","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.1038\/sj.onc.1203023","article-title":"Activation of Hex and mEg5 by retroviral insertion may contribute to mouse B-cell leukemia","volume":"18","author":"Hansen","year":"1999","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.cellsig.2025.111980_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1418","article-title":"LncRNA NEAT1 suppresses cellular senescence in hepatocellular carcinoma via KIF11-dependent repression of CDKN2A","volume":"13","author":"Chen","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111980_bb0110","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2023.5505","article-title":"Cyclovirobuxine D inhibits growth and progression of non-small cell lung cancer cells by suppressing the KIF11-CDC25C-CDK1-CyclinB1 G(2)\/M phase transition regulatory network and the NFkappaB\/JNK signaling pathway","volume":"62","author":"Xue","year":"2023","journal-title":"Int. J. Oncol."},{"issue":"15","key":"10.1016\/j.cellsig.2025.111980_bb0115","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/jnci\/82.15.1247","article-title":"Taxol: a novel investigational antimicrotubule agent","volume":"82","author":"Rowinsky","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cellsig.2025.111980_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100742","article-title":"Taxanes in cancer treatment: activity, chemoresistance and its overcoming","volume":"54","author":"Mosca","year":"2021","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.cellsig.2025.111980_bb0125","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.150.5.975","article-title":"Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5","author":"Kapoor","year":"2000","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111980_bb0130","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10637-015-0211-0","article-title":"First-in-human phase 1 study of filanesib (ARRY-520), a kinesin spindle protein inhibitor, in patients with advanced solid tumors","volume":"33","author":"LoRusso","year":"2015","journal-title":"Invest. New Drugs"},{"issue":"9","key":"10.1016\/j.cellsig.2025.111980_bb0135","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1158\/0008-5472.CAN-08-4373","article-title":"K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cells","volume":"69","author":"Nakai","year":"2009","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111980_bb0140","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/sj.bjc.6604264","article-title":"A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours","volume":"98","author":"Blagden","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111980_bb0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/CAD.0b013e32834e74d6","article-title":"Phase I dose-escalation and pharmacokinetic study of ispinesib, a kinesin spindle protein inhibitor, administered on days 1 and 15 of a 28-day schedule in patients with no prior treatment for advanced breast cancer","volume":"23","author":"Gomez","year":"2012","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.cellsig.2025.111980_bb0150","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.18-19-07822.1998","article-title":"Expression of the mitotic motor protein Eg5 in postmitotic neurons: implications for neuronal development","author":"Ferhat","year":"1998","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111980_bb0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-0854.2010.01152.x","article-title":"Inhibition of Kinesin-5, a microtubule-based motor protein, as a strategy for enhancing regeneration of adult axons","volume":"12","author":"Lin","year":"2011","journal-title":"Traffic"},{"key":"10.1016\/j.cellsig.2025.111980_bb0160","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ejmech.2013.01.031","article-title":"Advances in the discovery of kinesin spindle protein (Eg5) inhibitors as antitumor agents","volume":"62","author":"El-Nassan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111980_bb0165","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41419-022-05247-0","article-title":"The therapeutic effect of KSP inhibitors in preclinical models of cholangiocarcinoma","volume":"13","author":"Shi","year":"2022","journal-title":"Cell Death Dis."},{"issue":"13","key":"10.1016\/j.cellsig.2025.111980_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137230","article-title":"Small cell lung carcinoma cells depend on KIF11 for survival","volume":"25","author":"Sakuma","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111980_bb0175","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00280-010-1346-5","article-title":"A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose","volume":"67","author":"Holen","year":"2011","journal-title":"Cancer Chemother. Pharmacol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682500395X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682500395X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:33:06Z","timestamp":1762317186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682500395X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":35,"alternative-id":["S089865682500395X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111980","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KIF11 promotes AML progression, and its inhibition by SB-743921 suppresses disease advancement through mitotic G2\/M phase arrest","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111980","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111980"}}